Mr. Tathagata Adhikary, Jadavpur University, India

Dr. Tathagata Adhikary is a dedicated biomedical researcher with a Ph.D. in Biomedical Engineering from Jadavpur University, India. His academic journey spans a Master’s in Biomedical Engineering and a B.Tech in Biotechnology. With extensive research experience supported by prestigious fellowships, he has contributed to nanofertilizers, cancer therapy, and bioremediation. A skilled educator and published scholar, Dr. Adhikary has authored numerous journal articles and conference papers. He also serves as a reviewer for reputed scientific journals and has been invited as a guest speaker on clinical data management. His interdisciplinary approach reflects a passion for innovation in life sciences.

Publication Profile

Education

Mr. Tathagata Adhikary holds a Ph.D. in Biomedical Engineering from Jadavpur University, India. He earned his Master of Engineering (M.E) in the same field from Jadavpur University (2016–2018) with an impressive CGPA of 8.55/10. 🧬 Prior to that, he completed his B.Tech in Biotechnology from the National Institute of Technology, Durgapur (2012–2016), securing a CGPA of 7.03/10. 📘 His academic journey began at Sudhir Memorial Institute, West Bengal, where he achieved 76.4% in the All India Senior School Certificate Examination (2011), following a strong foundation at Aditya Academy, with 84.5% in his 10th board exams (2009).

Experience

Mr. Tathagata Adhikary has rich research experience, having served as a Senior Research Fellow (June 2022–June 2024) at Jadavpur University, funded by the Department of Higher Education, West Bengal. He was previously a Junior Research Fellow (Aug 2019–Mar 2021) under TEQIP-III and also worked on a NMHS-sponsored project (Aug 2018–July 2019) at NIT Arunachal Pradesh 🌱. In teaching, he conducted practicals and classes in Cell and Molecular Biology for M.E students 🧫 as part of his SRF role at Jadavpur University, contributing to academic excellence with up to six sessions per week 📚.

Awards

Mr. Tathagata Adhikary has made notable academic contributions and achievements. He serves as a reviewer for prestigious journals such as Plant Nano Biology (Elsevier BV) 🧪, Journal of Drug Design and Medicinal Chemistry (Science Publishing Group) 💊, and Technium: Romanian Journal of Applied Sciences and Technology (TechniumScience) ⚙️. He was invited as a guest speaker for a “Value Added Course – Clinical Data Management” organized by Brainware University, India 🎤. Additionally, he qualified the highly competitive GATE 2016 exam in Biotechnology, securing an impressive all-India rank of 822 🏅, demonstrating his academic excellence.

Research Focus

Tathagata Adhikary’s research primarily focuses on interdisciplinary applications in biotechnology, healthcare, and nanotechnology. His work includes studies on phytochemicals, enzyme analysis, oil-water separation, and the biodegradation of pollutants using microbial processes. He also explores the therapeutic potential of natural products like turmeric for wound healing and cancer therapy, emphasizing the integration of computational biology and nanotechnology in drug discovery. His research extends into sustainable practices in agriculture with nanofertilizers and the development of biosensors for healthcare. This diverse body of work contributes to both environmental and health-related innovations.

Publication Top Notes

The internet of things (iot) augmentation in healthcare: An application analytics

Phytochemical analysis and comparative study of antibacterial effect of turmeric extracts using different solvent.

Extraction and separation of oils: the journey from distillation to pervaporation

Enzymes analysis, degradation kinetics, response surface optimization and heavy metal tolerance of the biodegradation of malachite green by Stenotrophomonas koreensis

Cellulases in paper and pulp, brewing and food industries: Principles associated with its diverse applications

Revisiting Therapeutic Potentials of Ethanolic Extract of Curcuma longa L. rhizomes to Evaluate wound Healing Progression upon Topical Application of its Ointment

The paradigm shift towards utilizing nanofertilizers paves a promising future in industrial agriculture and soilless cultivation

Trends in Biosensors and Role of Enzymes as Their Sensing Element for Healthcare Applications

In-silico Approach to Investigate the Phytochemicals of Terminalia arjuna as Multitarget Inhibitors of Proteins Involved with Lung Cancer

Software for Drug Discovery and Protein Engineering: A Comparison Between the Alternatives and Recent Advancements in Computational Biology

Optimization of the Process Parameters to Develop Green‐Synthesized Nanostructures with a Special Interest in Cancer Theranostics

Jameel Al-Tamimi | Biopharmaceutics | Best Researcher Award

Posted on 25/04/202525/04/2025 by sciencefather

Jameel Al-Tamimi | Biopharmaceutics | Best Researcher Award

Dr. Jameel Al-Tamimi, King Saud University, Saudi Arabia

Dr. Jameel Al-Tamimi is a distinguished researcher with a Ph.D. in Immunogenetics from King Saud University, Riyadh, Saudi Arabia. His research focuses on immunology, particularly the role of Killer Immunoglobulin-like Receptors (KIRs) in leukemia. He has expertise in molecular techniques, immunology, and forensic entomology. Dr. Al-Tamimi has published numerous research articles and has contributed to various academic committees. His teaching experience spans courses in molecular biology, human physiology, and medical entomology.

Publication Profile

Google Scholar

Education

Dr. Jameel Al-Tamimi 🎓 is a distinguished researcher with a Ph.D. in Immunogenetics (Excellent 4.9/5) from King Saud University, where his thesis explored the Role of Killer Immunoglobulin-like Receptors (KIRs) with HLA Ligands in Saudi Leukemia Patients 🧬. He also holds an M.Sc. in Entomology and Parasitology (Excellent 4.9/5), investigating the anti-inflammatory effects of Pachycondyla sennaarensis (Samsum Ant) venom in male albino rats 🐜🧪. Dr. Al-Tamimi earned his B.Sc. in Biology (Very Good 89.9/100) from Thamar University, Yemen, with research focused on physiological changes in viral hepatitis (HbsAg and HCV) patients at Thamar Hospital 🧫🦠.

Experience

Dr. Jameel Al-Tamimi 🧑‍🔬 brings a wealth of academic and research experience. Since 2023, he has served on the Scientific Committee for the Researcher Support Program (RSPD) and Research Groups Program (RGP) at the Deanship of Scientific Research 📚. At King Saud University, he contributed to key committees, including labs, academic accreditation, exams, and graduate studies 🏛️. He supervised both the endocrinology and immunology laboratories 🧪 and mentored undergraduate and master’s students 🎓. Skilled in handling rats, mice, and insects 🐭🦗, Dr. Al-Tamimi is also proficient in advanced molecular biology, immunology, and physiology techniques 🧬🔬.

Awards

Dr. Jameel Al-Tamimi 🎓 has been recognized for his academic excellence with several prestigious awards. In 2015, he received an acknowledgment certificate from the Chairman of the Center of Excellence in the Development of Science and Mathematics Education at King Saud University 🏅, highlighting his contribution to scientific advancement. Earlier, in 2013, he was honored with a Certificate of Appreciation (General Prize) during the first Graduate Student Annual Scientific Meeting at KSU 📜🎉. These achievements reflect his dedication to academic excellence, innovation in research, and commitment to the scientific community 🌟📚.

Research Focus

Dr. Jameel Al-Tamimi is a multidisciplinary biomedical researcher whose primary focus lies in oxidative stress, wound healing, diabetes, and nanoparticle therapeutics. His work spans nanomedicine, immunomodulation, and natural product pharmacology, particularly in evaluating the biological activities of camel milk peptides, selenium and zinc oxide nanoparticles, and bioactive plant extracts. Dr. Al-Tamimi’s studies contribute significantly to redox biology, diabetic complications, and biofabrication of therapeutic agents, offering innovative strategies for combating chronic diseases and enhancing healing processes. 🧫💊🐫 His collaborative work reflects a strong emphasis on toxicology, regenerative medicine, and bio-nanotechnology.

Publication Top Notes

Camel milk peptide improves wound healing in diabetic rats by orchestrating the redox status and immune response

Wound healing of different molecular weight of hyaluronan; in-vivo study‏

Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress‏

Synthesis, structural characterization of silver (I)-NHC complexes and their antimicrobial, antioxidant and antitumor activities‏

Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide‏

Efficacy of a Methanolic Extract of Adansonia digitata Leaf in Alleviating Hyperglycemia, Hyperlipidemia, and Oxidative Stress of Diabetic Rats‏

Antioxidant Bioactivity of Samsum Ant (Pachycondyla sennaarensis) Venom Protects against CCL₄‐Induced Nephrotoxicity in Mice‏

Biofabrication of Zinc Oxide Nanoparticle from Ochradenus baccatus Leaves: Broad‐Spectrum Antibiofilm Activity, Protein Binding Studies, and In Vivo Toxicity …‏

Charbel Fadel | Pharmacology | Best Researcher Award

Posted on 25/04/202525/04/2025 by sciencefather

Charbel Fadel | Pharmacology | Best Researcher Award

Dr. Charbel Fadel, University of Pisa, Italy

Dr. Charbel Fadel is a renowned researcher in Veterinary Pharmacology with a PhD from the University of Sassari, Italy. He specializes in pharmacotherapy, quality control, and pharmacokinetics. Currently, Dr. Fadel is a Research Fellow at the University of Pisa, Italy, overseeing pharmacology lab operations and conducting animal studies. With a rich background in veterinary medicine, he has contributed to numerous scientific publications and presented at prestigious international conferences. Dr. Fadel’s work is focused on drug disposition, antimicrobial resistance, and improving veterinary pharmacology practices globally. He holds multiple honors and continues to impact veterinary science.

Publication Profile

Scopus

Education

Dr. Charbel Fadel is a distinguished veterinarian with extensive academic qualifications. He earned his Ph.D. in Veterinary Pharmacology, Pharmacotherapy, and Quality Control from the University of Sassari, Italy, in October 2023. Prior to this, he completed a Master’s degree in Veterinary Medicine, specializing in Small Animals’ Medicine, at L’Université Libanaise, Lebanon, in October 2020. His expertise in veterinary pharmacology and small animal care, combined with a passion for enhancing animal health, defines his professional journey.

Experience

Dr. Charbel Fadel has a rich professional background in veterinary medicine. Currently, he serves as a Research Fellow in Veterinary Pharmacology at the University of Pisa, Italy, where he oversees lab operations, manages pharmacokinetic studies, and collaborates with international teams to refine pharmacotherapy strategies. Before this, he was the Project and Operations Manager at IVet Medical in Beirut, Lebanon. In this role, he provided expert guidance to veterinarians on the use of biomedical machines, biological tests, and surgical instruments, while also managing the procurement and evaluation of medical supplies.

Awards

Dr. Charbel Fadel has earned numerous honors throughout his career. He has been an active reviewer for the Journal of Veterinary Pharmacology and Therapeutics since 2023 and was awarded the “Cultore della Materia” honor by the University of Pisa in January 2024 for his work as a Subject Specialist/Adjunct Lecturer. He received second runner-up for the 2023 JVPT Paper Award from Wiley Publishers, and his article on robenacoxib pharmacokinetics was recognized as the most cited in 2022-2023. Dr. Fadel also contributed to the “Rocinate Program” and completed several veterinary training programs in Russia.

Research Focus

Dr. Charbel Fadel’s research focus lies in veterinary pharmacology, particularly in the comparative pharmacokinetics of various drugs in livestock species like sheep and goats. His studies, including those on metronidazole and omeprazole, aim to enhance the understanding of drug absorption, distribution, metabolism, and excretion in these animals. This research is crucial for optimizing veterinary care and ensuring effective medication dosages in different animal species. Dr. Fadel’s work supports the development of more tailored and efficient treatment protocols for livestock, contributing to both animal health and agricultural practices.

Publication Top Notes

Comparative pharmacokinetic evaluation of metronidazole in sheep and goats

Comparative Pharmacokinetics of Intravenous and Subcutaneous Omeprazole in Sheep and Goats

Daotong Li | Psychopharmacology | Best Researcher Award

Posted on 25/04/202525/04/2025 by sciencefather

Daotong Li | Psychopharmacology | Best Researcher Award

Prof. Dr. Daotong Li, China Agricultural University, China

Prof. Dr. Daotong Li is an Associate Professor at China Agricultural University’s College of Food Science and Nutritional Engineering. His research focuses on dietary nutrition, gut microbiota, and food-medicine homology. He has led national research projects and published in top-tier journals like Science Bulletin, Microbiome, and Critical Reviews in Food Science and Nutrition, with over 800 citations and two ESI Highly Cited Papers. 🌱🧬 He has served as Secretary of the International Association of Dietetic Nutrition and Safety and was honored as an “Outstanding Talent” by China Agricultural University in 2022.

Publication Profile

Scopus

Education

Prof. Dr. Daotong Li has an impressive academic background spanning multiple disciplines and institutions. He earned his Ph.D. in Agricultural Products Processing and Storage Engineering from China Agricultural University (2015–2019), with a joint Ph.D. training in Immunology at the renowned Weizmann Institute of Science in Israel (2017–2018) 🌍🔬. Earlier, he completed his Master’s degree in Basic Veterinary Science at South China Agricultural University (2011–2014) 🐾, following a Bachelor’s degree in Animal Inspection and Quarantine from Shanxi Agricultural University (2007–2011) 🐄📘. His diverse educational journey reflects a deep commitment to advancing agricultural and biomedical sciences.

Experience

Prof. Dr. Daotong Li brings valuable experience in both academia and research. Since October 2022, he has been serving as an Associate Professor at the College of Food Science and Nutritional Engineering, China Agricultural University 🏫🥼. Prior to this, from September 2019 to September 2022, he worked as a Postdoctoral Researcher at the School of Basic Medical Sciences, Peking University 🔬🧠. His professional journey highlights a strong dedication to scientific advancement in food science, nutrition, and medical research, positioning him as a key contributor in these interdisciplinary fields .

Awards

Prof. Dr. Daotong Li has received prestigious recognitions for his academic excellence and research contributions. In 2019, he was honored as a “Boya Postdoctoral Fellow” by Peking University, a testament to his outstanding performance during his postdoctoral studies 🔬🎓. Later, in 2022, he was recognized as an “Outstanding Talent” by China Agricultural University 🌟🏫, reflecting his impactful work in food science and nutritional engineering. These accolades not only highlight his dedication to scientific research but also his rising influence in the academic community .

Research Focus

Prof. Dr. Daotong Li focuses on functional foods, nutritional biochemistry, and phytochemistry, with an emphasis on the health benefits of plant-derived compounds. His research explores the nutritional and therapeutic values of superfoods like quinoa 🧡, Houttuynia cordata 🌿, and the sustainable use of fruit and vegetable residues 🍊🥦. He also investigates gut microbiota 🦠, particularly how compounds like acrylamide affect intestinal health and conditions like colitis. His interdisciplinary work spans food science, toxicology, and natural product chemistry, contributing to advancements in functional nutrition 🍽️, sustainable food systems ♻️, and plant-based therapeutics .

Publication Top Notes

Quinoa: Nutritional and phytochemical value, beneficial effects, and future applications

Acrylamide drives amidase-mediated gut dysbiosis to aggravate colitis

The nutritional value, application status and challenges of Houttuynia cordata Thunb (H. cordata)

Sustainable Extraction Technology of Fruit and Vegetable Residues as Novel Food Ingredients

Shah Nawaz Khan | Pharmaceutical Chemistry | Best Researcher Award

Posted on 22/04/202522/04/2025 by sciencefather

Shah Nawaz Khan | Pharmaceutical Chemistry | Best Researcher Award

Dr. Shah Nawaz Khan, Shanghai Jiao Tong University, China

Dr. Shah Nawaz Khan, Ph.D. is a distinguished pharmaceutical chemist at Shanghai Jiao Tong University, specializing in organic synthesis, medicinal chemistry, and chemical biology. With a Ph.D. in Pharmaceutical Chemistry, his research spans photocatalytic decarboxylation, transition metal catalysis, and drug discovery. He has led projects on nucleoside antibiotics, shikonin derivatives, and natural product synthesis, contributing to cutting-edge solutions in biomedical innovation. Dr. Khan has an impressive publication record in high-impact journals and actively collaborates on international research initiatives.

Publication Profile

Orcid

Education

Dr. Shah Nawaz Khan 🎓 is a highly accomplished scholar in pharmaceutical sciences. He earned his Ph.D. in Pharmaceutical Chemistry from the School of Pharmacy, Shanghai Jiao Tong University 🇨🇳 (2016–2022). Prior to that, he completed his M.Phil. in Organic Synthesis at the University of Malakand 🇵🇰 (2012–2014), following his Doctor of Pharmacy degree from Gomal University (2004–2009). His academic journey began with an F.Sc. in Pre-Medical (2002–2004) and Matriculation in Science (2001–2002), both from Oxford Education Academy 🏫 in KPK, Pakistan. His strong educational foundation reflects a deep commitment to pharmaceutical research and academic excellence 🔬📚.

Experience

Dr. Shah Nawaz Khan 🔬 has extensive research experience in medicinal and pharmaceutical chemistry. Since Nov 2022, he has been a Postdoctoral Fellow at the School of Chemistry and Chemical Engineering, SJTU 🇨🇳, working on projects like the total synthesis of natural products (GR24), Ullmann coupling, and nucleoside synthesis. His Ph.D. (2016–2022) at SJTU focused on photocatalytic decarboxylative C-O, C-C, and C-N functionalization 🌟, using photoredox and transition metal catalysis. During his M.Phil. (2012–2014) at UOM 🇵🇰, he explored pharmacological activities and synthesized amide derivatives through one-pot reactions. His work bridges synthetic innovation and biological significance 🧪💊.

Awards

Dr. Shah Nawaz Khan 🏅 has been honored with several awards and certificates recognizing his academic, professional, and extracurricular contributions. He received certificates of appreciation for workshops and seminars on faculty development, allied health sciences, and nursing (2020–2022) 🎓. He earned a Personal Protective Equipment Training certificate during the COVID-19 pandemic 🦺 and was awarded the prestigious CSC Type A Scholarship 🇨🇳 in 2016. Earlier, he participated in the “GSK Gold Challenge” (2010), organized national-level declamation contests (2008), and alumni events (2007) 🗣️. Additionally, he holds over 10 sports certificates 🏆, reflecting a well-rounded and active educational journey.

Research Focus

Dr. Shah Nawaz Khan’s research centers on pharmaceutical chemistry and medicinal compound development, particularly emphasizing anticancer, antimicrobial, and antiviral agents. His work explores naphthoquinone derivatives, cyclopeptides, and photocatalytic processes, aiming to discover novel bioactive compounds for drug discovery and skin therapies. Additionally, he contributes to the understanding of molecular mechanisms of action and synthetic methodologies in organic chemistry. His research spans diverse fields including pharmacology, biotechnology, and chemical engineering, reflecting a multidisciplinary approach toward innovative therapeutic solutions. 🌱💊🧬 His cutting-edge investigations significantly impact disease treatment, drug design, and biomedical science.

Publication Top Notes

Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

A comprehensive study on the effects of annular protrusion for cavitation intensification in Venturi tubes

Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

Discovery of A Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening

Synthesis and germination activity study of novel strigolactam/strigolactone analogues

Decarboxylative oxidation-enabled consecutive C-C bond cleavage

Decarboxylative oxidation enabled consecutive C-C bond cleavage

Synthesis, characterization and antinociceptive activities of Novel 2-(2,4-dichlorophenyl)-4H-chromen-4-one

Pharmacological Activities and One Pot Two Step Synthesis of Novel (E)-N-(1-methyl-4-oxoimidazolidin-2-ylidene)benzamide

Nigatu Gebrehiwot | Precision Medicine | Best Researcher Award

Posted on 22/04/202522/04/2025 by sciencefather

Nigatu Gebrehiwot | Precision Medicine | Best Researcher Award

Dr. Nigatu Gebrehiwot, Zhengzhou University, China

Dr. Nigatu Gebrehiwot is a dedicated PhD candidate in Pharmacology at Zhengzhou University, China, specializing in drug safety evaluation. He holds a Master’s in Clinical and Administrative Pharmacy from Xi’an Jiaotong University and a Bachelor of Pharmacy from Mekelle University, where he was recognized as an outstanding student. A published researcher and global presenter, Dr. Gebrehiwot has earned accolades including recognition at ISPOR in Barcelona. He is actively involved in multiple international scientific societies and brings strong expertise in pharmacotherapy, academic writing, and collaborative healthcare research. His work explores methionine metabolism and innovative therapeutic strategies.

Publication Profile

Orcid

Education

Dr. Nigatu Gebrehiwot holds a Master’s degree in Clinical and Administrative Pharmacy from Xi’an Jiaotong University, where his research earned an award at the 21st European Congress ISPOR Health Outcome Research Conference in Barcelona, Spain. 🏅 He also earned a Bachelor’s degree in Pharmacy from Mekelle University, where he was recognized as the most outstanding student in his class. 🎓 His academic achievements reflect his dedication to advancing the field of pharmacy, blending clinical expertise with research excellence. Dr. Gebrehiwot’s work continues to impact the healthcare landscape positively.

Experience

Dr. Nigatu Gebrehiwot is currently a Ph.D. candidate in Pharmacology at the Center for Drug Safety Evaluation and Research, Zhengzhou University, Henan, China, since September 2022. 🎓 Prior to this, he served as the Principal Scientific Officer at the Federal Ministry of Health (FMOH) in Ethiopia from June 2020 to 2021. During his tenure, Dr. Gebrehiwot managed national disease programs and medicines, overseeing the funding and evaluation of treatment guidelines and drug therapy protocols in accordance with Ethiopian legislation and EFDA guidelines. 💊 He also led technical committees focused on antimicrobial therapy, cancer, and chronic disease management.

Awards

Dr. Nigatu Gebrehiwot received a prestigious award for his research abstract at the 21st European Congress ISPOR Health Outcome Research conference in Barcelona, Spain. 🏆 This recognition underscores the significant impact of his work in the field of pharmacology and health outcome research. 🌍 His contributions continue to advance knowledge and influence healthcare practices, making him a respected figure in his field. 💡 Dr. Gebrehiwot’s dedication to research excellence and his ability to address critical health issues have earned him well-deserved acknowledgment on an international stage.

Research Focus

Dr. Nigatu Tadesse’s research primarily focuses on molecular alterations in disease processes, with an emphasis on metabolic pathways and their potential as diagnostic and therapeutic targets. His work on gastric intestinal metaplasia and methionine metabolism sheds light on novel approaches to diagnosis and treatment. Additionally, Dr. Tadesse has contributed significantly to pharmacology, particularly the study of traditional medicines like Dioscorea zingiberensis, investigating its phytochemistry, clinical applications, and toxicity. His research also extends to industrial processes, such as wastewater treatment in diosgenin production. His interdisciplinary work connects biomedicine, pharmacology, and environmental science.

Publication Top Notes

Molecular Alterations in Gastric Intestinal Metaplasia Shed Light on Alteration of Methionine Metabolism: Insight into New Diagnostic and Treatment Approaches

Knowledge, attitude and antibiotic prescribing patterns of medical doctors providing free healthcare in the outpatient departments of public hospitals in Sierra Leone: A national cross-sectional study

Dioscorea zingiberensis C. H. Wright: An overview on its traditional use, phytochemistry, pharmacology, clinical applications, quality control, and toxicity

First total synthesis of a novel amide alkaloid derived from Aconitum taipeicum and its anticancer activity

Methods to treat the industrial wastewater in diosgenin enterprises produced from Diosorea zingiberensis C. H. Wright

Safety investigation on total steroid saponins extracts from Dioscorea zingiberensis C.H. Wright: Sub-acute and chronic toxicity studies on dogs

Kyle Frey | Pharmaceutical Manufacturing | Best Researcher Award

Posted on 21/04/202521/04/2025 by sciencefather

Kyle Frey | Pharmaceutical Manufacturing | Best Researcher Award

Mr. Kyle Frey, Quotient Sciences, United States

Mr. Kyle Frey is an exceptionally driven scientist and internationally recognized author with over 12 years of experience in pharmaceutical research and drug development. Specializing in formulation design, preformulation assessments, and manufacturing, he has contributed to advancements in pharmaceutical technologies, including resonant acoustic mixing (RAM) for low-dose blending. Kyle has been honored as a Distinguished Scientist by Marquis Who’s Who and is a sought-after technical expert in the field. With a strong foundation in medical school training at Thomas Jefferson Medical College, he excels in solving complex challenges and advancing innovations in pharmaceutical science.

Publication Profile

Orcid

Education

Kyle Frey pursued an ambitious academic journey, starting with his time at Thomas Jefferson Medical College, where he completed two years of coursework in the M.D. program (08/2010 – 12/2012). Although he did not obtain the degree, his education included in-depth studies in pharmacokinetics, biochemistry, molecular biology, anatomy, neurology, and immunology. Prior to this, he earned a Bachelor of Arts in Pre-Medicine from the University of Delaware (09/2006 – 05/2010), graduating summa cum laude with a 3.942 GPA. He was also a Phi Beta Kappa member, received a full scholarship for his last two years, and earned Dean’s List honors. 🎓

Experience

Kyle Frey is currently serving as a Formulation Scientist III at Quotient Sciences, where he has been since January 2020. His role involves assessing novel APIs using various characterization techniques such as thermal analysis, solubility, and bulk/physical tests. He leads preformulation activities, including excipient selection, compatibility testing, and stability studies, presenting findings and designing laboratory studies. Kyle also develops and optimizes pharmaceutical formulations, resolves formulation issues, and supports GMP manufacturing for clinical trials. He collaborates with cross-functional teams, prepares technical documents, and mentors junior scientists. His expertise includes working with high-potent molecules. 🔬💊

Research Focus

Kyle Frey’s research focuses on the innovative application of Resonant Acoustic Mixing Technology for enhancing the uniformity of low-dose pharmaceutical blends. This technology aims to streamline the process of blending ultra-low doses of active pharmaceutical ingredients (APIs) in a single-step mixing process, improving precision and reducing potential errors in dosage. His work is crucial in the fields of pharmaceutical engineering, formulation science, and drug delivery systems, where blending efficiency directly impacts drug effectiveness and patient safety. Frey’s contributions are pivotal in advancing pharmaceutical manufacturing technologies..

Publication Top Notes

Sample preparation techniques to enhance uniformity of Low-Dose blends mixed by resonant acoustic mixing technology

Use of Resonant Acoustic Mixing Technology for Ultra-Low-Dose Blending in a Single-Step Mixing Process

Use of Resonant Acoustic Technology for Ultra-Low Dose Blending in a Single-Step Mixing Process

Padmavati Manchikanti | Pharmaceutical Law and Ethics | Best Researcher Award

Posted on 21/04/202521/04/2025 by sciencefather

Padmavati Manchikanti | Pharmaceutical Law and Ethics | Best Researcher Award

Prof. Dr. Padmavati Manchikanti, Indian Institute of Technology Kharagpur, India

Prof. Dr. Padmavati Manchikanti, a Ph.D. in Plant Sciences, brings over 16 years of interdisciplinary expertise bridging biotechnology, pharmaceutical law, and intellectual property. A faculty member at IIT Kharagpur since 2006, her work spans drug regulations, patent law, telemedicine, and medical device policy. She has led government-funded research on herbal therapeutics, metabolic engineering, and immunization policy. With several international patents, a Springer-published book on AI in healthcare, and over 1,600 citations, she remains a driving force in biotech innovation and regulatory science.

Publication Profile

Scopus

Education

Prof. Dr. Padmavati Manchikanti 🌿 holds a Ph.D. in Plant Sciences and brings over four years of biotech industry experience. Since 2006, she has been engaged in teaching and research at IIT Kharagpur 🎓. With more than sixteen years of expertise in pharmaceutical law, regulation ⚖️, and intellectual property rights 📜, her research spans cross-country drug law comparisons, drug regulation implementation in India, clinical trial standards, and patent issues related to pharmaceuticals 💊. Her work also explores patent linkage, biodrug patenting, and the evolving landscape of telemedicine patenting and regulation 📡, making her a leading voice in this vital interdisciplinary field.

Experience

Prof. Dr. Padmavati Manchikanti 🌿 has led several impactful research projects across diverse scientific domains. In 2018, she developed a herbal biodegradable therapeutic dressing for traumatic wound care 🩹, funded by the Department of Science and Technology, GOI. The same year, she evaluated Basella species for antioxidant potential and nutraceutical development 🍃, supported by the Government of West Bengal. Earlier, in 2013, she synthesized and characterized bioactive peptides from honey protein 🍯 under CSIR. She also established the Plant Metabolic Pathways Laboratory 🌱 in 2011 with MHRD support and studied international drug price control mechanisms 💊 in 2009 under the Department of Pharmaceuticals.

Professional Memberships

Prof. Dr. Padmavati Manchikanti 🤝 holds esteemed memberships in several prestigious professional organizations, reflecting her interdisciplinary expertise. She is a member of the Association of Teachers and Researchers in Intellectual Property (ATRIP) 📘 and the International Trademark Association ®️. Her global engagement includes past membership in the World Bioenergy Association 🌍 and active involvement in the Federation of Asian Biotechnology Association (FABA) 🧬. Additionally, she is a member of AFBIC at IIT Kharagpur 🎓. These affiliations highlight her strong commitment to advancing knowledge and collaboration in intellectual property, biotechnology, energy, and innovation.

Research Focus

Prof. Dr. Padmavati Manchikanti’s research primarily focuses on telemedicine, remote patient monitoring, food authenticity, and sustainable extraction techniques. Her work on telemedicine tools explores innovations in remote health monitoring, emphasizing cross-country patent analysis. She also investigates issues like honey adulteration and its authentication, addressing global challenges in food safety and quality. Additionally, her research in green extraction techniques involves ultrasound-assisted methods to extract phenolic components from plants like Basella alba, contributing to sustainable food production and health benefits.

Publication Top Notes

Patenting telemedicine tools: A cross-country analysis of technologies related to remote patient monitoring

Honey Authentication: A review of the issues and challenges associated with honey adulteration

Ultrasound assisted green extraction of phenolic components from Basella alba

Comparative Perspectives on the Protection of Food Geographical Indications in Asian Countries

Zhi-Ming Shao | Precision Medicine | Best Researcher Award

Posted on 16/04/202516/04/2025 by sciencefather

Zhi-Ming Shao | Precision Medicine | Best Researcher Award

Prof. Zhi-Ming Shao, Fudan University Shanghai Cancer Center, China

Prof. Zhi-Ming Shao is a distinguished surgical oncologist and global leader in breast cancer research. A graduate of Shanghai Medical University, he chairs the Department of Breast Surgery at Fudan University Shanghai Cancer Center and directs its Breast Cancer Institute. With extensive postdoctoral experience in the U.S. and over 30 years of academic excellence, Prof. Shao has received numerous national honors, including the Chang Jiang Scholar and China’s Most Beautiful Doctor Award. His groundbreaking research, published in top journals like Nature Genetics and Cancer Cell, has significantly advanced precision oncology and breast cancer therapy worldwide.

Publication Profile

Scopus

Education

Prof. Zhi-Ming Shao began his medical journey at Shanghai Medical University, where he earned his Bachelor of Medicine (1980–1985). Driven by a passion for cancer treatment, he pursued a Residency in Surgical Oncology (1985–1990) at the prestigious Fudan University Shanghai Cancer Center. During this period, he also completed his Doctor of Medicine (M.D.) through a Postgraduate Course in Surgical Oncology (1987–1990) at Shanghai Medical University. His comprehensive education laid a strong foundation for his distinguished career in oncology, combining clinical expertise with academic excellence.

Experience

Prof. Zhi-Ming Shao has undergone extensive professional training and leadership roles in oncology. He began as a Postdoctoral Research Fellow (1990–1991) at Wake Forest University, followed by a role as Research Associate (1991–1995) at the University of Maryland Cancer Center. Returning to China, he became Associate Professor (1996–1998) and then Professor (1998–present) at Fudan University Shanghai Cancer Center. Since 2000, he has chaired the Department of Breast Surgery and became Director of the Breast Cancer Institute (2019–present). He also served as Chairman of the 8th Asian Breast Cancer Association (2010–2012) and is now Honorary Chairman of the China Anti-Cancer Association.

Awards

Prof. Zhi-Ming Shao has received numerous prestigious honors and awards throughout his career. In 1998, he was named one of the first batch of distinguished professors of the Chang Jiang Scholars Program. He was awarded the National Science Fund for Distinguished Young Scholars in 2001 and recognized as a Young and Middle-aged Expert with Outstanding Contributions by the Ministry of Health of China in 2004. His accomplishments include the National Prize of Science and Technology Progress (Grade II) in 2005, the National May Day Labor Medal in 2008, and the Chinese Physician Prize in 2020. He was also honored with the 2023 China’s Most Beautiful Doctor Award.

Research Focus

Prof. Zhi-Ming Shao’s research focuses on breast cancer, particularly in the areas of pathogenesis and treatment strategies. His work explores novel therapeutic approaches, such as targeting specific pathways involved in triple-negative breast cancer (TNBC) and HER2-positive breast cancer, as well as developing targeted imaging agents for improved diagnosis. Prof. Shao has contributed significantly to understanding the molecular mechanisms of breast cancer progression and therapy resistance. His studies involve investigating genetic markers, tumor microenvironment interactions, and new treatment combinations. Overall, his research aims to improve clinical outcomes for breast cancer patients, especially in advanced or resistant cases.

Publication Top Notes

Breast cancer: pathogenesis and treatments

Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4

LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer

Pilot Study of Nectin-4–Targeted PET Imaging Agent ⁶⁸Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human

Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial

The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer

O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression

Symptoms Related to Brachial Plexus Neuropathy After Supraclavicular Irradiation and Boost in Breast Cancer

Prognostic value of metabolic signature on 18F-FDGuptake in breast cancer patients after radiotherapy

TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer

jun ou | Nanomedicine | Best Academic Researcher Award

Posted on 16/04/202516/04/2025 by sciencefather

jun ou | Nanomedicine | Best Academic Researcher Award

Prof. Dr. jun ou, Guilin University of Technology , China

Prof. Dr. Jun Ou is a renowned materials scientist specializing in biomaterials and nanotechnology. With a Ph.D. from Sichuan University, he serves as a professor at Guilin University of Technology. His expertise spans degradable bio-metals, upconversion nanomaterials, and smart drug delivery systems. He has served as a visiting scholar in Australia and Germany and has received multiple honors, including the Best Researcher Award 2023. Prof. Ou has published widely in high-impact journals and delivered talks at international conferences, contributing significantly to biomedical material innovation.

Publication Profile

Scopus

Education

Prof. Dr. Jun Ou is a distinguished academic with extensive qualifications in biomaterials and related fields. He earned his Ph.D. in Biomaterials from the University of Sichuan’s School of Materials Science and Engineering, where he studied from 2004 to 2010. Earlier, he completed his M.Sc. in Inorganic Chemistry at Guangxi Normal University between 2001 and 2003. His academic journey began with a Bachelor of Science in Engineering from the University of Science and Technology of Chengdu, where he studied from 1982 to 1986. His diverse academic background has laid a strong foundation for his contributions to the field of biomaterials.

Experience

Prof. Dr. Jun Ou has extensive teaching experience in Science and Engineering. From 2010 to 2022, he taught undergraduate and graduate courses at Guilin University of Technology, including “Introduction to Metallurgical Transmission Principles” and “Degradable Bio-Metal” focusing on novel ophthalmic materials. He designed course curricula, organized lectures, and graded assignments. As a professor, he has shared his expertise in Materials Science, Metallurgy, Physics, Inorganic Chemistry, Thermodynamics, and more, educating students worldwide. In addition, he has held visiting scholar positions, including at the Australian National University and Bundesanstalt für Materialforschung und-prüfung in Germany.

Awards

Prof. Dr. Jun Ou has received numerous prestigious awards and honors throughout his distinguished career. In 2023, he was honored with the Best Researcher Award at the International Research Awards on Advanced Nanomaterials and Nanotechnology. In 2022, he was named the Outstanding Open Science Author of the Year by Wiley-China. He also received the CSC Government of China Scholarship Council award in 2013 for his research project on rare earth nanomaterials and their application in constructing nano carbon monoxide carrier release systems, a three-year project that showcased his innovative contributions to nanotechnology and materials science.

Research Focus

Prof. Dr. Jun Ou is a prominent researcher in the field of luminescent materials and nanophosphors, with a specific focus on upconversion luminescence, optical temperature sensing, and lanthanide-doped materials. His work explores the design and enhancement of rare-earth-doped phosphors like NaYF₄: Yb, Ho and Er³⁺/Tm³⁺ systems for efficient green emission and thermometric applications. He also delves into nanoparticle-mediated nitric oxide delivery for biomedical applications like brain tumors. 🚀 His innovative use of Mn doping and 808 nm NIR excitation advances both materials science and nanomedicine, contributing significantly to next-gen optical sensors and bioimaging technologies.

Publication Top Notes

Synchronous realization of green upconversion emission enhancement and optical temperature sensitivity improvement in phosphors NaYF₄: Yb, Ho via Mn doping

Promising lanthanide- NaYbF₄:Er³⁺@NaYbF₄:Tm³⁺ micro-phosphors for highly efficient upconversion luminescence and temperature sensing

Preliminary investigation of nitric oxide release from upconverted nanoparticles excited at 808 nm near-infrared for brain tumors

Corrigendum to “The synthesis of Er³⁺/Yb³⁺/K⁺ triple-doped NaYF₄ phosphors and its high sensitivity optical thermometers at low power” J. Alloys Compd. 937 (March) (2023) 168299 (Journal of Alloys and Compounds (2023) 937, (S0925838822046904), (10.1016/j.jallcom.2022.168299))